Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06571513 · ClinicalTrials.gov registry record · NA

Written Exposure Therapy to Improve Recovery Among Sexual Assault Survivors

A NA study of Post Traumatic Stress Disorder, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06571513 is a NA study of Post Traumatic Stress Disorder that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 30 participants, below the 1,117-participant average among 144 other Post Traumatic Stress Disorder trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06571513, a NA study of Post Traumatic Stress Disorder, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The main objective of this pilot trial is to determine the feasibility and initial efficacy of telehealth-delivered written exposure therapy to reduce the development of posttraumatic stress disorder after sexual assault. This pilot trial will provide the data necessary to design and support a large-scale trial.

Interventions

  • BEHAVIORAL Written Exposure Therapy
  • BEHAVIORAL Unemotional Writing

Study Locations (1)

North Carolina

  • University of North Carolina at Chapel Hill - Chapel Hill

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2024-09-23
Est. Completion 2026-03-07
Phase NA

What the Registry Record Tells You About NCT06571513

The ClinicalTrials.gov registry entry for NCT06571513 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,117-participant average among 144 other Post Traumatic Stress Disorder trials with a reported enrollment target (97% lower). The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 2 interventions - of which Written Exposure Therapy is the first listed.

NCT06571513 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT06571513 about?

NCT06571513 is a clinical study titled "Written Exposure Therapy to Improve Recovery Among Sexual Assault Survivors". The main objective of this pilot trial is to determine the feasibility and initial efficacy of telehealth-delivered written exposure therapy to reduce the development of posttraumatic stress disorder after sexual assault. This pilot trial will provide the data necessary to design and support a large...

What is the current status of trial NCT06571513?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2024-09-23. Estimated completion is 2026-03-07.

What conditions does trial NCT06571513 study?

This clinical trial studies the following conditions: Post Traumatic Stress Disorder.

What interventions are being tested in trial NCT06571513?

The interventions under investigation include: Written Exposure Therapy (BEHAVIORAL), Unemotional Writing (BEHAVIORAL).

Who is sponsoring clinical trial NCT06571513?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06571513 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Post Traumatic Stress Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.